You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gedatolisib

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Tumor Malignant Female Trial in United States (Gedatolisib)

Available
  • Breast Neoplasm Malignant Female
  • Gedatolisib
  • Birmingham, Alabama
  • +4 more
Jul 25, 2022

Breast Cancer Trial (Gedatolisib, Palbociclib, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • Gedatolisib
  • +3 more
  • (no location specified)
Aug 12, 2022

Lung Cancer Squamous Cell, Solid Tumors, Head & Neck Cancer Trial in Boston (Palbociclib, Gedatolisib)

Recruiting
  • Lung Cancer Squamous Cell
  • +3 more
  • Boston, Massachusetts
  • +2 more
Jan 9, 2023

Breast Cancer Trial in Los Angeles, Bronx (Gedatolisib, Faslodex, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Gedatolisib
  • +3 more
  • Los Angeles, California
  • +1 more
Jan 25, 2022

TNBC - Triple-Negative Breast Cancer Trial in United States (Gedatolisib, Talazoparib)

Recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Chicago, Illinois
  • +4 more
Jan 18, 2022

HER2-positive Breast Cancer, Metastatic Breast Cancer Trial in Seoul (Trastuzumab biosimilars(Herzuma), Gedatolisib)

Unknown status
  • HER2-positive Breast Cancer
  • Metastatic Breast Cancer
  • Trastuzumab biosimilars(Herzuma), Gedatolisib
  • Seoul, Korea, Republic of
    Samsung Medical Center
Feb 16, 2021

Triple Negative Breast Cancer, Metastatic Breast Cancer Trial in Indianapolis (Gedatolisib, PTK7-ADC)

Completed
  • Triple Negative Breast Cancer
  • Metastatic Breast Cancer
  • Indianapolis, Indiana
    IU Simon Cancer Center
Jan 5, 2021

Breast Cancer Trial in Philadelphia (Hydroxychloroquine (HCQ), Gedatolisib)

Withdrawn
  • Breast Cancer
  • Hydroxychloroquine (HCQ)
  • Gedatolisib
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 24, 2020

Tumor Trial in Worldwide (PF-05212384 (gedatolisib), Docetaxel, Cisplatin)

Completed
Has Results
  • Neoplasm
  • PF-05212384 (gedatolisib)
  • +3 more
  • Birmingham, Alabama
  • +28 more
Sep 9, 2021

NSCLC Trial in Gainesville (Gedatolisib, Paclitaxel, Carboplatin)

Terminated
Has Results
  • Non-Small Cell Lung Cancer
  • Gedatolisib
  • +2 more
  • Gainesville, Florida
    UF Health Cancer Center
Oct 2, 2019

Breast Cancer, NSCLC, Ovary Cancer Trial in Bellinzona (PF-05212384, Paclitaxel, Carboplatin)

Completed
  • Breast Cancer
  • +5 more
  • Bellinzona, TI, Switzerland
    Oncology Institute of Southern Switzerland (IOSI)
May 20, 2019

Therapy-related Acute Myeloid Leukemia and Myelodysplastic Syndrome, Acute Myeloid Leukemia, in Relapse, de Novo Acute Myeloid

Terminated
  • Therapy-related Acute Myeloid Leukemia and Myelodysplastic Syndrome
  • +2 more
  • Paris, Ile De France, France
  • +4 more
Feb 4, 2019

Metastatic Colorectal Cancer Trial in Worldwide (PF-05212384, irinotecan, Cetuximab)

Terminated
Has Results
  • Metastatic Colorectal Cancer
  • Bakersfield, California
  • +31 more
Dec 19, 2018

Endometrial Tumors Trial in Worldwide (PF-05212384)

Terminated
Has Results
  • Endometrial Neoplasms
  • Birmingham, Alabama
  • +50 more
Dec 19, 2018

Tumors Trial in Spain, United Kingdom, United States (PF-05212384 (also known as PKI-587))

Completed
Has Results
  • Neoplasms
  • PF-05212384 (also known as PKI-587)
  • Boston, Massachusetts
  • +8 more
Mar 5, 2018

Advanced Cancer Trial in Worldwide (PF-05212384, PD-0325901, irinotecan)

Terminated
Has Results
  • Advanced Cancer
  • Los Angeles, California
  • +17 more
Feb 13, 2018

Metastatic Colorectal Carcinoma Trial in Canada, Spain, United States (PF-05212384, FOLFIRI regimen, Bevacizumab)

Terminated
Has Results
  • Metastatic Colorectal Carcinoma
  • Fullerton, California
  • +38 more
Jul 8, 2016

Healthy Trial in Ruddington Fields (PF-05212384)

Completed
  • Healthy
  • Ruddington Fields, Nottingham, United Kingdom
    Pfizer Investigational Site
Sep 2, 2014